Huo Guanlin, Lin Yumeng, Liu Lusheng, He Yuqi, Qu Yi, Liu Yang, Zhu Renhe, Wang Bo, Gong Qing, Han Zhongyu, Yin Hongbing
College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China.
Health Management Center, Nanjing Tongren Hospital, School of Medicine, Southeast University, Nanjing, China.
Front Pharmacol. 2024 Dec 6;15:1509172. doi: 10.3389/fphar.2024.1509172. eCollection 2024.
As a mechanism of cell death, ferroptosis has gained popularity since 2012. The process is distinguished by iron toxicity and phospholipid accumulation, in contrast to autophagy, apoptosis, and other cell death mechanisms. It is implicated in the advancement of multiple diseases across the body. Researchers currently know that osteosarcoma, osteoporosis, and other orthopedic disorders are caused by NRF2, GPX4, and other ferroptosis star proteins. The effective relief of osteoarthritis symptoms from deterioration has been confirmed by clinical treatment with multiple ferroptosis inhibitors. At the same time, it should be reminded that the mechanisms involved in ferroptosis that regulate orthopedic diseases are not currently understood. In this manuscript, we present the discovery process of ferroptosis, the mechanisms involved in ferroptosis, and the role of ferroptosis in a variety of orthopedic diseases. We expect that this manuscript can provide a new perspective on clinical diagnosis and treatment of related diseases.
作为一种细胞死亡机制,铁死亡自2012年以来受到广泛关注。与自噬、凋亡及其他细胞死亡机制不同,该过程以铁毒性和磷脂堆积为特征。它与身体多种疾病的进展有关。研究人员目前已知骨肉瘤、骨质疏松症及其他骨科疾病是由NRF2、GPX4等铁死亡关键蛋白引起的。多种铁死亡抑制剂的临床治疗已证实可有效缓解骨关节炎症状恶化。同时,应提醒的是,目前尚不清楚铁死亡调节骨科疾病的具体机制。在本手稿中,我们介绍了铁死亡的发现过程、铁死亡涉及的机制以及铁死亡在多种骨科疾病中的作用。我们期望本手稿能为相关疾病的临床诊断和治疗提供新的视角。